Compositions For The Treatment Of Inflammation Of The Gastrointestinal Tract

Patent No. EP2214677 (titled "Compositions For The Treatment Of Inflammation Of The Gastrointestinal Tract") was filed by Meritage Pharma on Nov 12, 2008. The application was issued on Aug 30, 2017.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
DR FALK PHARMA	May 22, 2018	KELLER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Dec 12, 2019
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Dec 12, 2019
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Dec 9, 2019
Termination of the opposition proceedings with revocation of patent
Nov 5, 2019
Advice of delivery
Sep 6, 2019
Advice of delivery
Sep 6, 2019
Advice of delivery
Aug 30, 2019
Advice of delivery
Aug 28, 2019
Acknowledgement of a document
Aug 28, 2019
Acknowledgement of a document
Aug 28, 2019
Decision revoking the European patent
Aug 28, 2019
Decision revoking the European patent
Aug 19, 2019
(Electronic) Receipt
Aug 19, 2019
Letter accompanying subsequently filed items
Aug 19, 2019
Request for revocation of patent
Aug 12, 2019
(Electronic) Receipt
Aug 12, 2019
Letter accompanying subsequently filed items
Aug 12, 2019
Request for revocation of patent
Mar 27, 2019
Brief communication - Opposition proceedings
Mar 15, 2019
Any annexes (other than citation) to an opposition letter
Mar 15, 2019
Letter regarding the opposition procedure (no time limit)
Mar 15, 2019
Non-patent literature cited during the opposition procedure
Mar 15, 2019
Non-patent literature cited during the opposition procedure
Mar 6, 2019
Advice of delivery
Feb 14, 2019
Advice of delivery
Feb 14, 2019
Advice of delivery
Feb 12, 2019
Advice of delivery
Feb 7, 2019
Acknowledgement of a document
Feb 7, 2019
Acknowledgement of a document
Feb 7, 2019
Annex to the communication - opposition
Feb 7, 2019
Information concerning oral proceedings
Feb 7, 2019
Summons to attend oral proceedings
Feb 7, 2019
Summons to attend oral proceedings
Jan 31, 2019
Information about the result of oral proceedings
Oct 30, 2018
Brief communication - Opposition proceedings
Oct 23, 2018
(Electronic) Receipt
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Amended claims with annotations
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Claims
Oct 23, 2018
Letter accompanying subsequently filed items
Oct 23, 2018
Non-patent literature cited during the opposition procedure
Oct 23, 2018
Reply of the patent proprietor to the notice(s) of opposition
Jun 14, 2018
Communication of a notice of opposition and request to file observations
Jun 14, 2018
Notice of further oppositions to opponent(s)
Jun 1, 2018
Communication of a notice of opposition - first information to patent proprietor
May 22, 2018
Letter concerning fees and payments
May 22, 2018
Non-patent literature cited during the opposition procedure
May 22, 2018
Non-scannable object
May 22, 2018
Notice of opposition
May 22, 2018
Patent document cited during the opposition procedure
May 22, 2018
Patent document cited during the opposition procedure
May 22, 2018
Patent document cited during the opposition procedure
Aug 31, 2017
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Aug 3, 2017
Decision to grant a European patent
Jul 18, 2017
(Electronic) Receipt
Jul 18, 2017
Filing of the translations of the claims
Jul 18, 2017
French translation of claims
Jul 18, 2017
German translation of the claims
Jul 18, 2017
Letter accompanying subsequently filed items
Jun 26, 2017
Communication of the registration of a transfer or change of name and/or address
Jun 21, 2017
(Electronic) Receipt
Jun 21, 2017
Letter accompanying subsequently filed items
Jun 21, 2017
Submission concerning change of applicant's address
Mar 30, 2017
Bibliographic data of the European patent application
Mar 30, 2017
Communication about intention to grant a European patent
Mar 30, 2017
Intention to grant (signatures)
Mar 30, 2017
Text intended for grant (clean copy)
Mar 30, 2017
Text intended for grant (version for approval)
Jun 9, 2016
(Electronic) Receipt
Jun 9, 2016
Amended claims with annotations
Jun 9, 2016
Claims
Jun 9, 2016
Letter accompanying subsequently filed items
Jun 9, 2016
Reply to communication from the Examining Division
Apr 6, 2016
Annex to the communication
Apr 6, 2016
Communication from the Examining Division
Nov 12, 2015
Communication confirming withdrawal from representation
Nov 12, 2015
Communication of amended entries concerning the representative
Nov 9, 2015
(Electronic) Receipt
Nov 9, 2015
Letter accompanying subsequently filed items
Nov 9, 2015
Submission concerning change of applicant's representative
Oct 27, 2015
Submission concerning change of applicant's representative
Oct 16, 2015
Submission concerning change of applicant's representative
Oct 16, 2014
Submission concerning representation
Sep 5, 2014
Amended claims with annotations
Sep 5, 2014
Claims
Sep 5, 2014
Reply to communication from the Examining Division
Sep 2, 2014
Amended claims with annotations
Sep 2, 2014
Claims
Sep 2, 2014
Cover sheet for fax transmission
Sep 2, 2014
Letter accompanying subsequently filed items
Sep 2, 2014
Letter accompanying subsequently filed items
Sep 2, 2014
Reply to communication from the Examining Division
Apr 22, 2014
Annex to the communication
Apr 22, 2014
Communication from the Examining Division
Apr 14, 2014
Examination started
Apr 3, 2014
Amended claims filed after receipt of (European) search report
Apr 3, 2014
Amended claims with annotations
Apr 3, 2014
Amendments received before examination
Mar 20, 2014
Amended claims filed after receipt of (European) search report
Mar 20, 2014
Amended claims with annotations
Mar 20, 2014
Amendments received before examination
Mar 20, 2014
Cover sheet for fax transmission
Mar 20, 2014
Letter accompanying subsequently filed items
Mar 20, 2014
Letter accompanying subsequently filed items
Sep 12, 2013
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Aug 26, 2013
Communication of amended entries concerning the representative
Aug 26, 2013
Communication regarding the transmission of the European search report
Aug 26, 2013
European search opinion
Aug 26, 2013
Supplementary European search report
Aug 16, 2013
Search started
Aug 15, 2013
Submission concerning change of applicant's representative
Jun 3, 2013
Submission concerning representation
Apr 22, 2013
Communication of amended entries concerning the representative
Apr 15, 2013
Submission concerning change of applicant's representative
Nov 21, 2012
Communication of amended entries concerning the representative
Nov 15, 2012
Submission concerning change of applicant's representative
Sep 12, 2011
Submission concerning representation
Aug 2, 2010
(Electronic) Receipt
Aug 2, 2010
Amended claims filed after receipt of (European) search report
Aug 2, 2010
Amendments received before examination
Aug 2, 2010
Letter accompanying subsequently filed items
Aug 2, 2010
Matter concerning the application
Jul 16, 2010
Notification on forthcoming publication of bibliographic data
Jun 22, 2010
Communication regarding possible amendment of the application/payment of claims fee
Jun 3, 2010
Copy of the international preliminary report on patentability
May 13, 2010
(Electronic) Receipt
May 13, 2010
Request for entry into the European phase
May 13, 2010
Submission concerning representation
Mar 26, 2010
Information on entry into European phase
Aug 13, 2009
Copy of the international search report
Aug 13, 2009
International publication of the international search report
Jun 10, 2009
Priority document (electronically transmitted)
Jun 10, 2009
Priority document (electronically transmitted)
Jun 10, 2009
Priority document (electronically transmitted)
Jun 10, 2009
Priority document (electronically transmitted)
Jun 10, 2009
Priority document (electronically transmitted)
Jun 10, 2009
Priority document (electronically transmitted)
Jun 10, 2009
Priority document (electronically transmitted)
Jun 10, 2009
Priority document (electronically transmitted)
Jun 10, 2009
Priority document (electronically transmitted)
Jun 10, 2009
Priority document (electronically transmitted)
Jun 10, 2009
Priority document (electronically transmitted)
Jun 10, 2009
Priority document (electronically transmitted)
May 22, 2009
Published international application - A2

EP2214677

MERITAGE PHARMA

Application Number: EP08848917A
Filing Date: Nov 12, 2008
Status: Revoked; Dec 13, 2019
Publication Date: Aug 30, 2017
External Links: Slate, Register , Google Patents

IP Verse

Compositions For The Treatment Of Inflammation Of The Gastrointestinal Tract

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2214677